The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
The expanding universe of p53 targets
Abstract
The p53 tumour suppressor is modified through mutation or changes in expression in most cancers, leading to the altered regulation of hundreds of genes that are directly influenced by this sequence-specific transcription factor. Central to the p53 master regulatory network are the target response element (RE) sequences. The extent of p53 transactivation and transcriptional repression is influenced by many factors, including p53 levels, cofactors and the specific RE sequences, all of which contribute to the role that p53 has in the aetiology of cancer. This Review describes the identification and functionality of REs and highlights the inclusion of non-canonical REs that expand the universe of genes and regulation mechanisms in the p53 tumour suppressor network.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, results from multiple studies suggest that p53 can bind and transactivate target genes through noncanonical binding sites, particularly through half-sites.22, 54, 55, 56”
From Census and evaluation of p53 target genes (2017) · cites this paper as [55]
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
WebLogo: A Sequence Logo Generator: Figure 1Preprint
Crooks, G. E., Hon, G. C., Chandonia, J., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,418
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 567
Two p53 tetramers bind one consensus DNA response element
Kearns, S., Lurz, R., Orlova, E. V., & Okorokov, A. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw215 · Cited by 37
Discovery of Mieap‐regulated mitochondrial quality control as a new function of tumor suppressor p53
Nakamura, Y., & Arakawa, H. (2017) · Cancer Science · doi:10.1111/cas.13208 · Cited by 36
Emerging roles of long non-coding RNAs in the p53 network
Jain, A. K. (2020) · RNA Biology · doi:10.1080/15476286.2020.1770981 · Cited by 35
Pan, L.-Z., Ahn, D., Sharif, T., Clements, D. R., Gujar, S. A., & Lee, P. W. K. (2014) · Cell Cycle · doi:10.4161/cc.28128 · Cited by 37
Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
Chiang, M., Chou, P., Wang, W., Sze, C., & Chang, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00043 · Cited by 34
Tumor Suppressor Protein p53 Negatively Regulates Human Pregnane X Receptor Activity
Elias, A., Wu, J., & Chen, T. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085092 · Cited by 35
A p53 enhancer region regulates target genes through chromatin conformations in cis and in transPreprint
Link, N., Kurtz, P., O’Neal, M. A., Garcia-Hughes, G., & Abrams, J. (2013) · Genes & Development · doi:10.1101/gad.225565.113 · Cited by 37
Selvarajah, J., Nathawat, K., Moumen, A., Ashcroft, M. A., & Carroll, V. A. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.395 · Cited by 34
Kwon, S., Ma, S., Lee, S., & Jang, C. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.04.016 · Cited by 34
Gene-specific transcription activation via long-range allosteric shape-shifting
Tsai, C., & Nussinov, R. (2011) · Biochemical Journal · doi:10.1042/bj20110972 · Cited by 35
Recognition of Local DNA Structures by p53 Protein
Brázda, V., & Coufal, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020375 · Cited by 41
Ashraf, R., Hamidullah, Hasanain, M., Pandey, P., Maheshwari, M., Singh, L., Siddiqui, M. Q., Konwar, R., Sashidhara, K. V., & Sarkar, J. (2017) · Scientific Reports · doi:10.1038/srep45287 · Cited by 33
Construction and validation of a TP53-associated immune prognostic model for gastric cancer
Nie, K., Zheng, Z., Wen, Y., Shi, L., Xu, S., Wang, X., Zhou, Y., Fu, B., Li, X., Deng, Z., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.08.026 · Cited by 34
The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer
Nagao, K., Koshino, A., Sugimura‐Nagata, A., Nagano, A., Komura, M., Ueki, A., Ebi, M., Ogasawara, N., Tsuzuki, T., Kasai, K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063252 · Cited by 34
RB and p53 Cooperate to Prevent Liver Tumorigenesis in Response to Tissue Damage
McClendon, A. K., Dean, J. L., Ertel, A., Fu, Z., Rivadeneira, D. B., Reed, C. A., Bourgo, R. J., Witkiewicz, A. K., Addya, S., Mayhew, C. N., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.046 · Cited by 33
p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus
Menéndez, D., Snipe, J. R., Marzec, J. M., Innes, C. L., Polack, F. P., Caballero, M. T., Schurman, S. H., Kleeberger, S. R., & Resnick, M. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128626 · Cited by 35
Self-citationLow-level p53 expression changes transactivation rules and reveals superactivating sequences
Jordan, J. J., Menéndez, D., Sharav, J., Beno, I., Rosenthal, K., Resnick, M. A., & Haran, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205971109 · Cited by 33
Self-citationStructural Basis for p53 Lys120-Acetylation-Dependent DNA-Binding Mode
Vainer, R., Cohen, S., Shahar, A., Zarivach, R., & Arbely, E. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.009 · Cited by 33
Zhao, X., Liu, J., Liu, S., Yang, F., & Chen, E. (2019) · Cancers · doi:10.3390/cancers11111722 · Cited by 32
Altura, B. M., Shah, N. C., Shah, G. J., Zhang, A., Li, W., Zheng, T., Perez-Albela, J. L., & Altura, B. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00453.2011 · Cited by 33
Nonsense mutation-dependent reinitiation of translation in mammalian cells
Cohen, S., Kramarski, L., Levi, S., Deshe, N., David, O. B., & Arbely, E. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz319 · Cited by 35
Raimondi, I., Ciribilli, Y., Monti, P., Bisio, A., Pollegioni, L., Fronza, G., Inga, A., & Campomenosi, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069152 · Cited by 32
Self-citationIlluzzi, J. L., Vickers, C. A., & Kmiec, E. B. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9516-4 · Cited by 32
Yeo, S. Y., Itahana, Y., Guo, A. K., Han, R., Iwamoto, K., Nguyen, T., Bao, Y., Kleiber, K., Wu, Y., Bay, B., et al. (2016) · eLife · doi:10.7554/elife.07101 · Cited by 32
Kelkar, M. G., Thakur, B. L., Derle, A., Chatterjee, S., Ray, P., & De, A. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4297-2 · Cited by 31
Benosman, S., Meng, X., von Grabowiecki, Y., Palamiuc, L., Hriţcu, L., Groß, I., Mellitzer, G., Taya, Y., Loeffler, J., & Gaiddon, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261271 · Cited by 39
Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes
Haley, V., Barnes, D., Sandovici, I., Constância, M., Graham, C. F., Pezzella, F., Bühnemann, C., Carter, E. J., & Hassan, A. B. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101105 · Cited by 30
5-Lipoxygenase is a direct p53 target gene in humans
Gilbert, B., Ahmad, K. A., Roos, J., Lehmann, C., Chiba, T., Ulrich-Rückert, S., Smeenk, L., van Heeringen, S. J., Maier, T. J., Groner, B., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.004 · Cited by 31
Expression of MYSM1 is associated with tumor progression in colorectal cancer
Li, Y., Li, J., He, L., Liu, Y., & Cui, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177235 · Cited by 30
Fuzzy Tandem Repeats Containing p53 Response Elements May Define Species-Specific p53 Target Genes
Simeonova, I., Lejour, V., Bardot, B., Bouarich-Bourimi, R., Morin, A., Fang, M., Charbonnier, L., & Toledo, F. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002731 · Cited by 34
Polato, F., Rusconi, P., Zangrossi, S., Morelli, F., Boeri, M., Musi, A., Marchini, S., Castiglioni, V., Scanziani, E., Torri, V., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju053 · Cited by 30
Global re‐wiring of p53 transcription regulation by the hepatitis B virus X protein
Chan, C. S. C., Thurnherr, T., Wang, J., Gallart‐Palau, X., Sze, S. K., Rozen, S., & Lee, C. G. L. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.006 · Cited by 30
Wang, S., Weng, H., Zhang, Y., Long, Y., Li, Y., Niu, Y., Song, F., & Bu, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030534 · Cited by 31
ADP-ribosylation and intracellular traffic: an emerging role for PARP enzymes
Grimaldi, G., & Corda, D. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180416 · Cited by 30
The Role of p53/p21/p16 in DNA-Damage Signaling and DNA Repair
Kulaberoglu, Y., Gündoğdu, R., & Hergovich, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00015-x · Cited by 30
ERK1/2 activation mediated by the nutlin-3-induced mitochondrial translocation of p53
Lee, S., Shin, S. J., & Kim, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1764 · Cited by 29
Specific Recognition of p53 Tetramers by Peptides Derived from p53 Interacting Proteins
Gabizon, R., Brandt, T., Sukenik, S., Lahav, N., Lebendiker, M., Shalev, D. E., Veprintsev, D. B., & Friedler, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038060 · Cited by 29
Modulation of immune responses by the tumor suppressor p53
Lowe, J. M., Shatz, M., Resnick, M. A., & Menéndez, D. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.2 · Cited by 30
Self-citationp53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation
Cai, B., Hsu, P.-C., Hsin, I., Chao, C., Lu, M., Lin, H.-C., Chiou, S., Tao, P., & Chen, J.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041742 · Cited by 31
Altura, B. M., Shah, N. C., Li, Z., Jiang, X., Zhang, A., Li, W., Zheng, T., Perez-Albela, J. L., & Altura, B. T. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00671.2010 · Cited by 29
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.
Tang, J., Agrawal, T., Cheng, Q., Qu, L., Brewer, M. D., Chen, J., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055813 · Cited by 28
de Assis, L. V. M., & Isoldi, M. C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1210-4 · Cited by 27
The use of genetically modified mice in cancer risk assessment: Challenges and limitations
Eastmond, D. A., Vulimiri, S. V., French, J. E., & Sonawane, B. R. (2013) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.822844 · Cited by 28
Hsiao, B.-Y., Chen, C.-C., Hsieh, P.-C., Chang, T.-K., Yeh, Y., Wu, Y., Hsu, H., Wang, F.-F., & Chou, T. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0717-z · Cited by 28
Němcová, K., Havran, L., Šebest, P., Brázdová, M., Pivoňková, H., & Fojta, M. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.04.018 · Cited by 27
Cooperative interactions between p53 and NFκB enhance cell plasticity
Bisio, A., Zámborszky, J., Zaccara, S., Lion, M., Tebaldi, T., Sharma, V., Raimondi, I., Alessandrini, F., Ciribilli, Y., & Inga, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2545 · Cited by 27
Self-citationPham, T.-N. D., Ma, W., Miller, D., Kazakova, L., & Benchimol, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1274-6 · Cited by 27
Salvation of the fallen angel: Reactivating mutant p53
Yang, L., Wang, Z., Chen, Y., Petersen, R. B., Zheng, L., & Huang, K. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14572 · Cited by 27
Takahashi, P., Polson, A., & Reisman, D. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0623-z · Cited by 27
Liao, C., Xie, G., Zhu, L., Chen, X., Li, X., Lu, H., Xu, B., Ramot, Y., Paus, R., & Yue, Z. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.021 · Cited by 27
Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships
Mantovani, F., Zannini, A., Rustighi, A., & Sal, G. D. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.013 · Cited by 30
Liu, Y., Xu, F., Wang, Y., Wu, Q., Wang, B., Yao, Y., Zhang, Y., Han‐Zhang, H., Ye, J., Zhang, L., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10625 · Cited by 26
Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis
Park, K., Yun, H., Yoo, K., Ham, Y. W., Han, S., & Hong, J. T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-019-0503-7 · Cited by 26
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
Haider, N., Dutt, P., van de Kooij, B., Ho, J., Palomero, L., Pujana, M. Á., Yaffe, M. B., & Stambolic, V. (2020) · Oncogene · doi:10.1038/s41388-020-1361-x · Cited by 26
Ciribilli, Y., Andreotti, V., Menéndez, D., Langen, J.-S., Schönfelder, G., Resnick, M. A., & Inga, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010236 · Cited by 26
Self-citationAli, A., Bhatti, M. Z., Shah, A. S., Duong, H., Alkreathy, H. M., Mohammad, S. F., Khan, R. A., & Ahmad, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.635730 · Cited by 26
Monti, P., Ciribilli, Y., Bisio, A., Foggetti, G., Raimondi, I., Campomenosi, P., Menichini, P., Fronza, G., & Inga, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1845 · Cited by 26
Self-citationUltraviolet irradiation promotes FOXP3 transcription via p53 in psoriasis
Zhang, D., Chen, Y., Chen, L., Yang, R., Wang, L., Liu, W., Zhai, Z., & Shen, Z. (2016) · Experimental Dermatology · doi:10.1111/exd.12942 · Cited by 26
Ding, W., Tong, Y., Zhang, X., Pan, M., & Chen, S. (2016) · Scientific Reports · doi:10.1038/srep19793 · Cited by 25
Bimodal regulation of p21waf1protein as function of DNA damage levels
Buscemi, G., Ricci, C., Zannini, L., Fontanella, E., Plevani, P., & Delia, D. (2014) · Cell Cycle · doi:10.4161/15384101.2014.946852 · Cited by 25
The role of acetylation sites in the regulation of p53 activity
Wang, Y., Chen, Y., Chen, Q., Zhang, X., Wang, H., Wang, Z., Wang, J., & Tian, C. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05141-7 · Cited by 27
The complex architecture of p53 binding sites
Senitzki, A., Safieh, J., Sharma, V., Golovenko, D., Danin‐Poleg, Y., Inga, A., & Haran, T. E. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1283 · Cited by 25
Self-citationAn Updated View of the Roles of p53 in Embryonic Stem Cells
Ayaz, G., Yan, H., Malik, N., & Huang, J. L. (2022) · Stem Cells · doi:10.1093/stmcls/sxac051 · Cited by 26
Huart, A.-S., MacLaine, N. J., Narayan, V., & Hupp, T. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043391 · Cited by 27
García‐Escudero, R., Martínez‐Cruz, A. B., Santos, M., Lorz, C., Segrelles, C., Garaulet, G., Sáiz-Ladera, C., Costa, C., Buitrago-Pérez, Á., Dueñas, M., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-193 · Cited by 26
Ethayathulla, A. S., Nguyen, H. T., & Viadiu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408039 · Cited by 25
Limited cell-autonomous anticancer mechanisms in long-lived bats
Athar, F., Zheng, Z., Riquier, S., Zacher, M., Lu, J. Y., Zhao, Y., Volobaev, V. P., Alcock, D., Galazyuk, A. V., Cooper, L. N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59403-z · Cited by 26
Moxley, A. H., & Reisman, D. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3590 · Cited by 25
Tocci, P., Román, C., Sestito, R., Castro, V. D., Sacconi, A., Molineris, I., Paolini, F., Carosi, M., Tonon, G., Blandino, G., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-022-05538-6 · Cited by 26
Islam, M. R., Jiménez, T., Pelham, C. J., Rodova, M., Puri, S., Magenheimer, B. S., Maser, R. L., Widmann, C., & Calvet, J. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145284 · Cited by 25
Relevance of TP53 for CLL diagnostics
Catherwood, M. A., de Castro, D. G., Donaldson, D. M., Clifford, R. M., Mills, K., & Thornton, P. D. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205622 · Cited by 24
The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling
Gao, X. C., Chen, H., Liu, J., Shen, S., Wang, Q., Clement, T. M., Deskin, B., Chen, C., Zhao, D., Wang, L., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.07.010 · Cited by 28
Irreversible Transitions, Bistability and Checkpoint Controls in the Eukaryotic Cell Cycle
Tyson, J. J., & Novák, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00014-9 · Cited by 24
Estrogens, regulation of p53 and breast cancer risk: a balancing act
Jerry, D. J., Dunphy, K. A., & Hagen, M. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0244-7 · Cited by 23
p53 alters intracellular Ca2+ signaling through regulation of TRPM4
Kappel, S., Ross‐Kaschitza, D., Hauert, B., Rother, K., & Peinelt, C. (2022) · Cell Calcium · doi:10.1016/j.ceca.2022.102591 · Cited by 23
A novel oncoprotein Pirh2: rising from the shadow of MDM2
Wang, Z., Yang, B. R., Dong, L., Peng, B., He, X., & Liu, W. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01899.x · Cited by 24
Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis
Chander, H., Brien, C. D., Truesdell, P. F., Watt, K., Meens, J., Schick, C., Germain, D., & Craig, A. W. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0503-x · Cited by 23
In vitro binding properties of tumor suppressor p53 with PUMA and NOXA
Park, M.-J., Jeong, M. S., & Jang, S. B. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.001 · Cited by 25
Maghbooli, Z., & Hossein‐Nezhad, A. (2015) · BioMed Research International · doi:10.1155/2015/926567 · Cited by 22
Pivoňková, H., Šebest, P., Pečínka, P., Tichá, O., Němcová, K., Brázdová, M., Jagelská, E. B., Brázda, V., & Fojta, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.120 · Cited by 22
p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress
Tudzarova, S., Mulholland, P. J., Dey, A., Stoeber, K., Okorokov, A. L., & Williams, G. H. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1231281 · Cited by 23
p53 Dynamically Directs TFIID Assembly on Target Gene Promoters
Coleman, R. A., Qiao, Z., Singh, S. K., Peng, C. S., Cianfrocco, M. A., Zhang, Z., Piasecka, A., Aldeborgh, H., Basishvili, G., & Liu, W. L. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00085-17 · Cited by 24
Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
Charni, M., Molchadsky, A., Goldstein, I., Solomon, H., Tal, P., Goldfinger, N., Yang, P., Porat, Z., Lozano, G., & Rotter, V. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.119 · Cited by 21
Sammad, A., Luo, H., Hu, L., Zhao, S., Gong, J., Umer, S., Khan, A. A., Zhu, H., & Wang, Y. (2022) · Biology · doi:10.3390/biology11060839 · Cited by 22
Regulating the genome surveillance system: miRNAs and the p53 super family
Bailey, S. G., Sánchez-Elsner, T., Stephanou, A., Cragg, M. S., & Townsend, P. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0456-1 · Cited by 22
Transcription factor p53 and skin aging
Gritsenko, D., Orlova, O. A., Linkova, N. S., & Khavinson, V. K. (2017) · Advances in Gerontology · doi:10.1134/s2079057017020072 · Cited by 21
Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation
Cai, B., Chao, C., Huang, H., Lee, H.-Y., Kannagi, R., & Chen, J.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153681 · Cited by 21
P53 and Apoptosis in the Drosophila Model
Zhou, L. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-23629-8_6 · Cited by 20
Lysine120 Interactions with p53 Response Elements can Allosterically Direct p53 Organization
Pan, Y., & Nussinov, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000878 · Cited by 21
Negative control of CSL gene transcription by stress/DNA damage response and p53
Menietti, E., Xu, X., Ostano, P., Joseph, J., Lefort, K., & Dotto, G. P. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1186317 · Cited by 20
Brázda, V., Čechová, J., Battistin, M., Coufal, J., Jagelská, E. B., Raimondi, I., & Inga, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.113 · Cited by 20
Self-citationPhan, T. T. T., Truong, N. V., Wu, W., Su, Y.-C., Hsu, T.-S., & Lin, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01638-0 · Cited by 20
Pan, Y., & Nussinov, R. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002077 · Cited by 21
p53 Dimers Associate with a Head-to-Tail Response Element to Repress Cyclin B Transcription
Lipski, R., Lippincott, D. J., Durden, B. C., Kaplan, A. R., Keiser, H. E., Park, J., & Levesque, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042615 · Cited by 20
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
Malesci, A., Basso, G., Bianchi, P. P., Fini, L., Grizzi, F., Celesti, G., Caro, G. D., Delconte, G., Dattola, F., Repici, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.827 · Cited by 20
Functional mimicry of the acetylated C‐terminal tail of p53 by a SUMO‐1 acetylated domain, SAD
Cheema, A. K., Knights, C. D., Rao, M., Catania, J., Perez, R. E., Simons, B. L., Dakshanamurthy, S., Kolukula, V. K., Tilli, M. T., Furth, P. A., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22224 · Cited by 22
Identification and characterization of a metastatic suppressor BRMS 1L as a target gene of p53
Koyama, R., Tamura, M., Nakagaki, T., Ohashi, T., Idogawa, M., Suzuki, H., Tokino, T., & Sasaki, Y. (2017) · Cancer Science · doi:10.1111/cas.13420 · Cited by 20
Enthalpy−Entropy Contribution to Carcinogen-Induced DNA Conformational Heterogeneity
Liang, F., & Cho, B. P. (2009) · Biochemistry · doi:10.1021/bi901629p · Cited by 19
Fukuda, R., Suico, M. A., Koyama, K., Omachi, K., Kai, Y., Matsuyama, S., Mitsutake, K., Taura, M., Morino‐Koga, S., Shuto, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442442 · Cited by 19
Fomina‐Yadlin, D., Kubicek, S., Vetere, A., He, K. H., Schreiber, S. L., & Wagner, B. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028808 · Cited by 17
Metadata
- Authors
- Menendez, D., Inga, A., & Resnick, M. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Resnick, Michael A.
- Venue
- Nature Reviews Cancer
- Published
- 2009-10
- Volume
- 9
- Issue
- 10
- Pages
- 724-737
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2094375196
- Cited by
- 568
- References
- 208
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 11 · 2023: 17 · 2022: 28 · 2021: 18 · 2020: 23 · 2019: 28 · 2018: 31 · 2017: 42 · 2016: 44 · 2015: 44 · 2014: 54 · 2013: 59 · 2012: 56
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (Z01ES065079)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- p53, transcriptional regulation, tumour suppressor, p53 target genes, p53 transactivation, transcriptional repression, cancer etiology
- MeSH terms
- Humans, Mutation, Neoplasms, Gene Expression, Genes, p53, Tumor Suppressor Protein p53, Response Elements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review